Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT02785185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-122 Lotion (0.01% Halobetasol Propionate) to Ultravate® (Halobetasol Propionate) Cream, in the Treatment of Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study.
Study identification
- NCT ID
- NCT02785185
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Interventions
- IDP-122 Vehicle Lotion Drug
- IDP-122 Vehicle Cream Drug
- IDP-122 Lotion Drug
- Ultravate Cream Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2016
- Primary completion
- Dec 1, 2016
- Completion
- Dec 31, 2016
- Last update posted
- Aug 26, 2020
2016 – 2017
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 05 | Rogers | Arkansas | 75758 | — |
| Valeant Site 10 | Beverly Hills | California | 90210 | — |
| Valeant Site 09 | Carlsbad | California | 92008 | — |
| Valeant Site 13 | Los Angeles | California | 90045 | — |
| Valeant Site 12 | Santa Monica | California | 90404 | — |
| Valeant Site 07 | Coral Gables | Florida | 33134 | — |
| Valeant Site 11 | North Miami Beach | Florida | 33162 | — |
| Valeant Site 03 | Sanford | Florida | 32771 | — |
| Valeant Site 08 | Albany | Indiana | 47150 | — |
| Valeant Site 04 | Louisville | Kentucky | 40202 | — |
| Valeant Site 06 | Fridley | Minnesota | 55432 | — |
| Valeant Site 02 | High Point | North Carolina | 27262 | — |
| Valeant Site 01 | Houston | Texas | 77065 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02785185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 26, 2020 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02785185 live on ClinicalTrials.gov.